Literature DB >> 20868843

De novo development of eosinophilic myocarditis with left ventricular assist device support as bridge to transplant.

Naveen L Pereira1, Soon J Park, Richard C Daly, Sudhir S Kushwaha, William D Edwards.   

Abstract

The de novo development of myocarditis during left ventricular assist device support for dilated cardiomyopathy has not been previously described. We report a case of severe eosinophilic myocarditis associated with the use of leukotriene-receptor antagonist montelukast that developed during left ventricular assist device support accompanied by intra-device thrombus formation that was hemodynamically tolerated and subsequently discovered in the explanted heart. There may be no visible change in cardiac function as assessed by echocardiography, but the diagnosis should be entertained with the development of peripheral eosinophilia.
Copyright © 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20868843     DOI: 10.1016/j.athoracsur.2010.03.029

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Total artificial heart implantation for biventricular failure due to eosinophilic myocarditis.

Authors:  Masashi Kawabori; Chitaru Kurihara; Yair Miller; Kent A Heck; Roberta C Bogaev; Andrew B Civitello; William E Cohn; O H Frazier; Jeffrey A Morgan
Journal:  J Artif Organs       Date:  2017-03-27       Impact factor: 1.731

2.  Eosinophilic myocarditis.

Authors:  U Baandrup
Journal:  Herz       Date:  2012-12       Impact factor: 1.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.